All the biotech and pharma hits in one daily email.

TLDR Biotech

Daily coverage of the biotech and pharma industry, straight to your inbox and all in one email.

Trusted by 2700+ biotech and pharma professionals.

Don't know what this is all about? See the FAQ section below 👇👇

TESTIMONIALS

What People Are Saying

I recommend TLDR Biotech to just about everyone - our founders, our co-investors, and even grad students who want to keep up with the must-know biotech news. It's one of the few newsletters I'm excited to open - it's got all the news I need to know, and in an easy-to-read format.

Susanna Harris

Director of Platform, Breakout Ventures

TLDR Biotech packs tons of useful information (good, bad, and ugly) into each daily newsletter. It's an easy, quick way to stay up to date on industry news, with links to more when you want to take a deep dive. I recommend it for staying on top of a rapidly changing industry as well as for business development fuel.

Heather Johnson

Chief Content Officer, OutWord Bound Communications

One of the key characteristics of being a great strategic consultant is to be on top of what is going on in the life sciences environment. The TLDR Biotech newsletter is one of the many ways I keep myself updated. It is very easy to digest and to the point!

Natalia Eitel

Manager, Vintura Consultancy

I love TLDR Biotech and find it very useful to get a pulse of what is going on in my field of interest and overall in biotech.

Anonymous

Senior Director of Regulatory CMC in Biotech

The TLDR newsletter is a great resource, I’ve really enjoyed its well-curated selection of industry updates, presented in a digestible format.

William Harley

Senior Bioengineer

The TLDR Biotech newsletter is hands down my favorite biotech newsletter. The unique structure, which breaks down stories into The Good, The Bad, and The Ugly, really makes it stand out. What I appreciate most is the formatting of the news. It not only reports what's happening but also includes valuable context like the type of API, indication, dosing, therapeutic area, and other relevant details. It's the only newsletter I make a point to read every day!

Matthias Lucke

Director Business Development at Coriolis Pharma

TLDR has become my go-to for easily accessible and organised BioPharma news. I love the way that all headlines are organised by category and is presented in an easy to read, informative and fun way.

Philip Robinson

BioPharma and Healthtech Consultant at Philip Robinson Consulting

TLDR Biotech has relentlessly delivered an incredible skim of biotech industry news, mergers, acquisitions, and regulatory updates for a full calendar year. I recommend this (free) newsletter, full of irreverent headlines, links to relevant announcements, and the occasional dad-joke meme, to young and old colleagues alike, and it's become a ritualistic part of my working mornings. The content is of highest quality, and the format is digestible and entertaining to read. If you only subscribe to one biotech email newsletter, and need to stay on top of biotech and pharma news in all its formats - small molecule to biologics, stem cells to CAR-T, start ups to commercial launches - let TLDR Biotech be the one.

Mark Omobono

Senior Engineer, TG Therapeutics

What I appreciate about [the TLDR Biotech] newsletter is how easy to read it is. I really like that you don't write more than necessary about any of the news but rather provide links for further info. This way I definitely read it entirely and not stop halfway through.

Urska Rauter Gaber

Business Development Associate, Lenis farmacevtika d.o.o.

I go through cycles of newsletter subscriptions/cancellations. Right now I'm really appreciating TLDR Biotech: - Digestible summaries with links out to full reporting. - Covered from a clinical development + M&A perspective - More personality than the standard industry update - Free

Steve Wimmer

Vice President of Partnerships, 1nHealth

I love the formatting, the GIFs are always spot on, and it's really easy to skim/read.

Whitney Symons

Senior Customer Success Manager at Inventia Life Science

The TLDR newsletter pulls me in with the humor and keeps my attention with its on-point industry news summaries. Thanks to the TLDR team for saving me time every day.

Guy Bradley

Executive Vice President, Promoveo Health

I’ve really enjoyed [the TLDR Biotech] updates - both the information they convey and how it’s conveyed. We do a lot of work in the CGT space and I like having [these] updates as a reminder for me to keep active in reading up on information.

Mike Keens

CEO, Sabai Global

As a business developer in the drug discovery and preclinical field, staying updated is crucial. I highly recommend this biotech newsletter—it offers a well-curated selection of important developments, written in an engaging and fun way. It's the perfect way to break up my day while keeping me informed on the latest in the industry.

Matthew Delport

Business Development Manager, Drug Discovery Services

TLDR Biotech is my one-stop-shop for biotech industry news. This daily newsletter presents the most important stories of the day it in a cleaver, easy to understand way.

Anonymous

Analyst, Healthcare Investor Relations

TLDR Biotech is hugely valuable, and its the best thing I've found to keep me up to date in a quickly readable format.

Anonymous

Director, Technology at Biotech

I enjoy TLDR Biotech, it's a packed Cliff's Notes of what's going on in our space. Easy to skim, links to dig in, and good balance across the spectrum of positive and negative news.

Jack DiGiovanna

Chief Science Officer at Velsera

I like the comprehensive and digestible style. Not just the good stuff, but the bad and the ugly too. And in a quick-to-read format. Nice to have in my inbox!

Jeff Bissen

Director of Business Development, Coriolis Pharma

This is the first news letter I read almost daily and I personally find it super useful.

Greg Prikler

Director of Business Development, Mcule

TLDR Biotech has been an incredibly valuable resource to keep a pulse on the industry and get early notifications of important market signals. The presentation is clear, concise, and easy to consume, with a sprinkling of humor to keep it light. I read every update and learn something new from each one.

Brett Kinsler

Director of Licensing and Development, University of Rochester Center for Health + Technology

A great newsletter for Business Development. Organized for Action!

Jeanne Schow

SVP of Business Development at a Global CRO

Because maybe you're wondering, "Why is this the only biotech and pharma newsletter I'll actually need?"

Frequently Asked Questions

What is this newsletter about?

TLDR Biotech brings you the top biotech and pharma industry news and coverage, all compiled in an easy to skim newsletter delivered every weekday - with bonus deep dive content+interviews on the weekend.

What kind of content is included?

We compile the top biotech and pharma news into quick headlines with tags for easy skimming - no need to shuffle through 20+ emails a day to keep up with the industry.

What's so special about this newsletter?

The quickest skim newsletter ever - our daily compilations aren't meant for you to dive into or take up 30 mins of your day - just quickly run through it and see what news interests you, with links out to deeper coverage from reputable, third-party journalists or from direct press releases.

Who is this newsletter for?

Anyone that needs to keep up with the biotech/pharma industry as a whole. We have readers from all over - from scientists and program managers to business development, sales, investing, VC/PE, founders. We link out to deeper dive pieces from other source or original press releases, so you get as much or as little detail as you want.

Why will this biotech/pharma newsletter save me time?

This newsletter offers an efficient way to stay informed about the entire industry without having to comb through multiple sources. This M-F daily biotech/pharma digest allows you to quickly skim all major happenings, dive into areas of interest, and continuously broaden your industry knowledge. See a news story you want to dig further into? There's a link going out to a publication that does a deeper dive, so it's easy to get all the info you want about the pharma & biotech space, quickly!

How often is it published?

We aim to publish multiple times per week, but never more than once per day - likely to be published in the mornings Pacific Time.

Who's writing this newsletter?

As of writing this, it's Anis Fahandej-Sadi - not many folks with that name, so I'm pretty easy to find on LinkedIn. I did sales/BD in the biotech and life science industry for four years, and launched the first iteration of TLDR Biotech in April 2024.

How will I receive this newsletter?

Carrier pigeon. Just kidding - email, obviously.

Will there be any exclusive interviews or insider content?

Periodically, the newsletter may feature exclusive interviews with biopharma thought leaders, experts or executive profiles not available elsewhere. If you fit the above category and want to be included, reach out!

My toaster stopped working, what do I do?

Maybe this is what you're looking for? https://home.howstuffworks.com/how-to-repair-small-appliances1.htm

*All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks and brands does not imply endorsement.